Radiopharm Theranostics reported total assets of $60.13M and total liabilities of $37.81M for the quarter ended Jun 2026. This balance sheet covers 5 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2023 | Jun2024 | Dec2024 | Jun2025 | Jun2026 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & EquivalentsCash & Equiv. | 11.70M | 18.58M | 36.44M | 29.12M | 4.14M |
| Short-term InvestmentsInvestments (Current) | 0.04M | 0.04M | |||
| Cash & Current Investments | 11.70M | 18.62M | 36.48M | 29.12M | 4.14M |
| Receivables - NetNet Receivables | 4.47M | 0.99M | 6.25M | 10.40M | 17.45M |
| Receivables | 4.47M | 0.99M | 6.25M | 10.40M | 17.45M |
| Prepaid Assets | 0.29M | 1.67M | 0.34M | 0.34M | |
| Current Assets | 22.85M | 44.35M | 39.85M | 21.93M | |
| Non-Current Assets | |||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.06M | 0.06M | 0.05M | 0.05M | |
| Intangibles | 58.54M | 49.09M | 48.00M | 46.57M | 38.16M |
| Goodwill & Intangibles | 58.54M | 49.09M | 48.00M | 46.57M | 38.16M |
| Other Non-Current Assets | 3.00M | ||||
| Non-Current Assets | 49.19M | 48.10M | 46.63M | 38.21M | |
| Assets | 72.04M | 92.45M | 86.48M | 60.13M | |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payables | 5.12M | 10.86M | 3.14M | 9.34M | 10.53M |
| Payables | 5.12M | 10.86M | 3.14M | 9.34M | 10.53M |
| Accumulated Expenses | 4.18M | ||||
| Other Accumulated Expenses | 0.02M | ||||
| Short term Debt | 6.32M | 2.24M | 3.42M | 6.86M | |
| Current Taxes | 27.11M | 27.30M | 28.68M | 18.91M | |
| Current Deferred Revenue | 3.16M | 1.72M | 0.81M | ||
| Total Current Liabilities | 17.58M | 13.15M | 14.93M | 18.90M | |
| Non-Current Liabilities | |||||
| Pension | 0.40M | 0.41M | 0.45M | 0.70M | |
| Minority Interest | -0.77M | -1.20M | -1.92M | -2.36M | |
| Total Non-Current Liabilities | 27.11M | 27.30M | 28.68M | 18.91M | |
| Total Liabilities | 44.68M | 40.45M | 43.61M | 37.81M | |
| Shareholder's Equity | |||||
| Total Debt | 6.32M | 2.24M | 3.42M | 6.86M | |
| Common Equity | 45.58M | 27.35M | 52.00M | 42.87M | 22.32M |
| Liabilities and Shareholders Equity | 72.04M | 92.45M | 86.48M | 60.13M | |
| Retained Earnings | -119.35M | -127.79M | -154.73M | -174.39M |
Pull Radiopharm Theranostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RADX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RADX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RADX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();